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Abstract 
 
Purpose 
Malnutrition in head and neck cancer (HNC) treatment is common and associated 
with poorer morbidity and mortality outcomes. This trial aimed to improve 
nutritional status during radiotherapy using a novel method of training dietitians to 
deliver psychological techniques to improve HNC patients’ nutritional behaviours.  
 
Methods and Materials 
This trial used a stepped wedge randomised controlled design to assess the efficacy 
of Eating As Treatment (EAT). Based on Motivational Interviewing and Cognitive 
Behavioural Therapy, EAT was designed to be delivered by oncology dietitians and 
integrated into their clinical practice. During control steps, dietitians provided 
treatment as usual, before being trained in EAT and moving into the intervention 
phase.  The training was principles based and sought to improve behaviour change 
skills rather than provide specific scripts.  
 
Patients recruited (151 controls, 156 intervention)  to the trial were assessed at four 
time points (first and final week of Radiotherapy, four and twelve weeks post). The 
primary outcome was nutritional status at the end of RT as measured by the Patient 
Generated Subjective Global Assessment (PG-SGA).  
 
Results 
Patients who received the EAT intervention had significantly better scores on the 
primary outcome of nutritional status at the critical end of treatment time point (β=-
1.53 (-2.93 to -.13) p=.03). Intervention patients were also significantly more likely 
to: be assessed as well-nourished at each time point; lose a smaller percentage of 
weight have fewer treatment interruptions; present lower depression scores; and 
report a higher quality of life. Although not statistically significant, those who 
received the intervention had fewer and shorter unplanned hospital admissions.  
 
Conclusions 
This trial is the first of its kind to demonstrate the effectiveness of a psychological 
intervention to improve nutrition in HNC patients receiving radiotherapy. It 
provides a means to ameliorate malnutrition and the important related outcomes 
and consequently should be incorporated into standard care for patients receiving 
HNC radiotherapy.  
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INTRODUCTION 
Head and Neck Cancer (HNC) is the sixth most commonly diagnosed cancer 
worldwide1. Along with the rigours of treatment, HNC patients also face high rates of 
malnutrition2. Malnutrition while receiving cancer treatment is associated with 
increased morbidity3 and reduced survival4. It is a common reason for treatment 
interruption5, which reduces the effectiveness of radiotherapy (RT) and is strongly 
associated with increased mortality6. Therefore preventing malnutrition during RT is 
critical for improving both morbidity and mortality outcomes for HNC patients.  
 
Dietitian support during RT demonstrably improves nutrition for HNC patients7,8, 
however these interventions predominantly focus on dietetic advice rather than 
behavioural adherence. A recent comprehensive review of all nutritional 
interventions for HNC nutrition found no studies that focussed on patient behaviour 
change8. This is despite the strong evidence in other areas of health that behaviour 
change interventions and in particular cognitive behaviour therapy (CBT), are 
effective in improving nutrition9.  
 
The EAT trial builds on a promising pilot trial of a psychological intervention 
targeting behaviour, that found a significant benefit in survival over three years10. It 
is the first multi-centre randomised controlled trial of a psychological intervention to 
improve nutrition in HNC patients.  
 
Aims and Hypotheses 
The aim of this trial was to test the effectiveness of the Eating As Treatment (EAT) 
intervention. EAT is a dietitian-delivered intervention, designed to prevent 
malnutrition in patients with HNC undergoing RT.  
 
It was hypothesised that patients with HNC receiving the EAT intervention would 
have better nutritional status scores, as measured by the Patient-Generated 
Subjective Global Assessment (PG-SGA), during their last week of RT, compared 
with patients in the control condition who received usual care.  
 
Secondary hypotheses were that intervention patients would have benefits in other 
measures of nutrition, higher rates of treatment completion, fewer unplanned 
hospital admissions, shorter lengths of stay, lower depression scores, and higher 
quality of life.  
 
METHODS AND MATERIALS 
Detailed descriptions of the methods and intervention can be found in the published 
protocol11 but are described briefly below.  
 
Trial Design 
The trial was a stepped wedge cluster randomised controlled trial (RCT). The stepped 
wedge was used because the nature of the intervention required the dietitians to 
acquire new skills, making contamination highly likely if they were then to provide a 
control condition in a RCT randomised at the level of the individual. The alternative 
therefore was to randomise at the hospital level, however a standard cluster 
randomised controlled trial required more hospitals seeing high numbers of HNC 
patients than were available within Australia. A stepped wedge randomised 
controlled trial provided the same level of evidence with fewer required clusters 12,13. 
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In a stepped wedge trial, all clusters begin in the control condition and then progress 
in a randomised order to the intervention condition (see supplementary Figure).  
 
Site Recruitment 
Six major Australian hospitals were recruited through the XXXXX. The only trial site 
eligibility criterion was that of treating a minimum of 100 HNC patients per year. 
The participating hospitals were from: XXXXX, South Australia; XXXXX, Victoria; 
XXXXX, Western Australia; XXXXX, New South Wales; and two hospitals in 
XXXXX, Queensland. The two hospitals in XXXXX shared a dietetic department. As 
such, while they were treated separately for analysis, they progressed to the 
intervention period at the same time, effectively reducing the number of intervention 
progression steps in the stepped wedge to five.  
 
Randomisation 
The order in which each site received the intervention was randomised by an 
independent statistician using a uniform random number generator in STATA14. 
 
Participants 
Inclusion criteria 
Patients eligible for inclusion met the following criteria: aged 18 years or older; 
pathologically confirmed diagnosis of HNC, that is, cancer involving the 
nasopharynx, oropharynx, oral cavity, larynx, or hypopharynx, requiring definitive or 
postoperative radiotherapy with curative intent (chemoradiation permitted including 
neoadjuvant and adjuvant chemotherapy); receiving regional nodal irradiation;  
receiving a prescribed dose of at least 60 Gy; available for follow-up for at least 6 
months post study initiation; capacity to provide written informed consent. 
 
Exclusion criteria 
Criteria that made patients ineligible for inclusion were: inability to communicate in 
English; presence of organic brain diseases (impairing ability to complete 
questionnaires satisfactorily); likely insignificant oral or pharyngeal mucositis as a 
complication of radiotherapy treatment (patients with T1/T2 glottic carcinoma 
undergoing small-field radiotherapy or T1/T2 tonsil cancer undergoing unilateral 
treatment were excluded). 
 
Treatment 
Control 
During the control phase, each hospital delivered treatment as usual, making no 
changes to any part of their clinical care. 
 
Intervention 
The “Eating As Treatment” intervention attempted to prevent malnutrition by 
reframing eating as part of a patient’s RT treatment. To do this, oncology dietitians 
delivered EAT during their usual consultations with a weekly exposure while the 
patient was receiving RT, and then fortnightly thereafter. This frequency was in 
accordance with the national guidelines15 and therefore was expected to be 
comparable to control phase session frequency.  
 
EAT used CBT strategies and motivational interviewing (MI) consultation styles. 
These two approaches were distilled for specific use with HNC patients, who were 
struggling to maintain nutrition while receiving radiotherapy. The intervention was 
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successfully piloted by a clinical psychologist10 and further refined for delivery by 
dietitians. Training in the intervention was tested on XXXXX oncology dietitians, 
who found the training acceptable and feasible16.  
 
EAT was designed to be a standardized but not highly manualised intervention. This 
approach is better  integrated into existing clinical practices and less structured MI 
interventions have demonstrated significantly greater effect sizes than those that 
were highly manualised17. To achieve this, EAT was presented as a set of key 
principles and strategies (Figure 1) that could be implemented flexibly in different 
situations and contexts. Dietitians were trained in implementing these strategies 
regardless of dietetic advice or patient characteristics. EAT was designed to be 
delivered as part of existing practice, without requiring additional resources.  
 
<Figure 1 about here> 
Figure 1. Principles of EAT & EAT to LIVE 
 
The first principle of EAT referred to the MI interactional style of a collaborative, 
empathic conversation18 and guided the dietitians in constructing a conversation in 
which the patient reinforced their own reasons for change. Importantly it also 
avoided pushing the patient into creating arguments not to change, a common 
outcome of a clinician telling them what they should do.  
 
Once motivation for good nutritional behaviour had been established, it was 
supported by CBT strategies aiming to reinforce the likelihood that the behaviour 
would happen after the patient had gone home. Principles 2,3 and 4 (Figure 1), 
underpin these strategies and were operationalized through a collaborative 
nutritional plan. At home the patient would work through their daily list of 
behaviours and tick off each item as it was completed. Through the nutrition planner 
the dietitian was able to utilize strategies of self-generation18, self-monitoring19, 
having a concrete plan20, tailoring21, achievability22, and reinforcement and 
accountability23. Each of these strategies has been shown to be effective in changing 
nutritional behaviours in other populations.9 
 
In week five of RT, when the patient’s ability to eat was likely to have become 
impaired, dietitians conducted a nutritional assessment. This allowed them to 
discuss poor nutritional status in a non-confrontational way. Dietitians were then 
instructed to conduct the ‘Eat to LIVE’ conversation (Figure 1.). Each element used 
MI to avoid patient defensiveness and the creation of arguments against change. The 
conversation established the patient’s motivation to live; informed them of the poor 
outcomes associated with malnutrition; and subtly highlighted the variance between 
wanting to live and not performing nutritional behaviours that gave them the best 
chance of survival. This conversation required the dietitian to have the skill not to be 
confrontational or accusatory and relied heavily on the relationship they had built. 
Once the patient had articulated their motivation, the dietitian would then return to 
the other principles and strategies to translate this motivation into changes in dietary 
behaviours. 
 
Variations to the Eat to LIVE conversation were allowed in two cases. In the first 
case, if the patient was performing all the behaviours the dietitians recommended, 
then there would be no variance to highlight and instead the dietitian deployed 
encouragement. Secondly, was when the dietitian found themselves having the Eat to 
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LIVE conversation earlier than week five of RT. This was allowed but dietitians were 
instructed to have the conversation again at week five.  
 
Depression has been shown to be associated with malnutrition in HNC patients24,25 
and clinical depression may hinder the effectiveness of the EAT intervention by 
further reducing appetite and inhibiting the therapeutic relationship). To address 
this, dietitians were trained in how to administer the Patient Health Questionnaire-2 
(PHQ-2)26, a very brief depression screener derived from the first two items of the 
PHQ-9 described below. If the patient was screened as potentially depressed (PHQ-2 
≥3), the dietitian would notify their Radiation Oncologist and refer to whatever 
service their hospital had in place for psychological care.  
 
Training  
Dietitians received training in the EAT intervention as each site moved from the 
control to the intervention condition. Trainers, (clinical psychologists, behavioural 
researchers and dietitian) travelled to each hospital and provided an initial three 
days training which was supported by a ‘booster’ training session two months later. 
In addition, dietitians received regular telephone supervision to discuss cases and 
skills implementation with an EAT team clinical psychologist (XXXX).  
 
Throughout both the control and the intervention periods, dietitians were required to 
audio record their sessions with study participants. A random sample of 20% of these 
recordings were then coded by study staff blinded to participant allocation as well as 
the content of the intervention. These recordings formed the basis of treatment 
fidelity, described in much greater detail in Beck et al (2015)27.  
 
To support the uptake and deployment of the EAT intervention the trial used several 
systems change strategies. These involved consulting multiple key hospital staff; 
academic detailing through shadowing days; systems changes such as ensuring the 
patient’s RT was scheduled at a time when they could also see the dietitian; 
intervention performance, which was relayed back to managers; and provision of 
tools and resources such as stickers and water bottles prompting the EAT principles. 
 
Outcomes  
Outcome assessments were conducted by an independent researcher at four time 
points: first week of RT, last week of RT which was the primary endpoint, one-month 
post-RT, and three months post-RT.  
 
Primary Outcome 
The primary outcome of nutritional status at end of treatment was measured using 
the score (range= 1-49) of the Patient Generated Subjective Global Assessment scale 
(PG-SGA)28. The PG-SGA is considered the pre-eminent assessment in oncology 
nutrition29 where a higher score is considered a worse nutritional status. The scale is 
comprised of both a self-report questionnaire and a clinical assessment conducted by 
the researcher. It incorporates known prognostic factors of nutrition including 
weight change, dietary intake, gastrointestinal symptoms, changes in functional 
capacity, nutritional intake, metabolic stress, subcutaneous fat, muscle wasting, 
disease and treatment.  
 
Secondary outcomes 
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Nutritional Outcomes in addition to the scored PG-SGA were: the dietitian’s 
Subjective Global Assessment (SGA) (A= Well Nourished, B= Moderately 
Malnourished and C= Severely Malnourished.); percentage weight loss; and weight 
loss >10%.  
 
Depression was assessed using the validated Patient Health Questionnaire 9 (PHQ-
9)30. Participants were asked to rate (on a scale of 0–3) the frequency of various 
Major Depressive Episode criteria over the previous 2 weeks. It measures the severity 
depression from 0 to 27. 
 
Treatment interruptions and unplanned hospital admissions were extracted by chart 
review conducted by a local member of the study team as each patient completed the 
study. All other covariates (general demographics, tumour site, tumour stage, RT 
prescription, chemotherapy and surgery details) were collected in the same way.  
 
Quality of Life (QOL) was assessed using the European Organisation for Research 
and Treatment of Cancer, Core Quality of Life Questionnaire (EORTC QLQ-C30). 
This is a validated31 30-item self-report questionnaire designed to measure quality of 
life in patients with cancer. The questionnaire consists of five functional scales 
(physical, role, cognitive, emotional and social), three symptom scales (fatigue, pain, 
nausea and vomiting), a global health status scale, and six single items assessing the 
perceived financial impact of the disease and additional symptoms commonly 
reported by patients with cancer (dyspnoea, loss of appetite, insomnia, constipation 
and diarrhoea).  
 
Sample Size 
A sample size calculation found that 400 participants would provide 80% probability 
that the study would detect a difference between intervention and control periods at 
a two-sided .05 significance level. There were no published minimum clinically 
important differences for the PG-SGA, so the calculation used estimates from the 
pilot trial which found a significant difference in mortality was associated with a 2 
point change in the PG-SGA and a standard deviation of 710.   
 
Blinding 
All efforts were made to blind the outcome assessors to the intervention content and 
delivery. However, because the assessments took place in the participating hospitals, 
it was not possible to guarantee that the assessors were blind to intervention delivery 
via awareness that training had taken place. Due to the nature of the intervention it 
was not possible to blind the dietitians providing the intervention.  Participants were 
blinded to treatment allocation.  
 
Statistical Methods 
All analyses were carried out using STATA 1332. The primary outcome of nutritional 
status as measured by the PG-SGA was analysed using an intention to treat, Linear 
Mixed Models (LMM) regression. The assumptions of the linear mixed models were 
assessed by inspecting appropriate residual plots. The model, nominated in the 
protocol 33, used an unstructured covariance and included the following: 
 
Cluster level variables of intervention period to test the effectiveness of the EAT 
intervention, and hospital cluster; to adjust for differences between hospitals; 
Individual level variables of baseline PG-SGA, to adjust for differences in baseline 
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nutrition and improve the power to detect a difference; calendar time, to adjust for 
any background temporal effects that could have confounded the stepped-wedge 
design; assessment moment; to adjust for differences in nutrition throughout RT and 
recovery; and Tumour site and stage,  to adjust for any differences between groups’ 
nutritional status due to differences in malignancies. The model also included an 
interaction between intervention and assessment moment to allow the treatment 
effect to vary over RT time and compare the intervention effect at the end of 
treatment. The model included a random individual level intercept to account for the 
repeated measures on individuals over assessment moments, and a random 
coefficient for assessment moment to allow for heterogeneity in subject specific 
trends. 
 
Secondary outcomes were assessed using the same model without the interaction 
term to analyse the average across all time points. Percentage weight loss, depression 
(PHQ-9) and QOL (QLQ C30) were analysed using LMM while the categorical 
dietitians’ subjective global assessment of nutritional status (SGA) and >10% weight 
loss were analysed using logistic mixed effects models.  
 
Treatment interruption was analysed using a logistic regression.  Unplanned hospital 
admissions were analysed using a negative binomial regression. Both models 
included intervention period, baseline nutritional status, hospital and calendar time.  
 
Findings 
 
Between July 2013 and January 2016, 307 participants were recruited with the final 
follow-up assessment conducted in May 2016 (Figure 2). One of the six hospitals 
failed to recruit any patients and withdrew within the first 9 months, leaving 5 
hospitals across 4 intervention sites. Baseline characteristics for the control and the 
intervention periods are presented in Table 1 and suggest that periods were 
comparable.  
 
<Figure 2 about here> 
Figure 2. Consort diagram 
 
Fidelity 
Blind fidelity ratings of the session tapes yielded very high inter- and intra-rater 
reliability and showed that dietitians delivered the intervention satisfactorily to pre-
specified levels34. The Eat To Live conversation was utilised outside of week 5 in 14% 
of the sampled on-radiotherapy session recordings34.  
 
<Table 1 about here> 
 
Primary Outcome 
Nutritional status as measured by the PG-SGA, found that participants in the 
intervention group had significantly lower (better) scores than those in the control 
group at the end of RT (β=-1.53 CI -2.93 to -.13 p=.03)  (Table 2). A breakdown of the 
components of the PG-SGA is presented in Figure 3.  
 
<Table 2 about here> 
 
<Figure 3 about here> 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 Page 9 of 16 
Figure 3. Mean PG-SGA Parts A, B, C & D across all time points, overlayed with 95% 
CI of the model margins comparing intervention and controls 
 
Secondary Outcomes (Table 2) 
Nutritional Outcomes 
Those in the intervention group were significantly more likely to be in the Subjective 
Global Assessment (SGA) category A: Well-nourished or anabolic across all follow up 
time points.  
 
Almost all participants lost weight from baseline (304 of the 307) and the LMM 
regression showed controls lost a significantly higher percentage of their baseline 
weight. Significantly more control participants experienced more than 10% weight 
loss.  
 
Depression 
Patients in the intervention group had significantly lower depression scores than 
those in the control group. 
 
Treatment Interruptions 
Twenty-one controls (14%) experienced RT treatment interruptions compared to 12 
(8%) in the intervention, a difference that was statistically significant.  
 
Unplanned Hospital Admissions 
Those in the control condition had more unplanned hospital admissions than those 
in the intervention for a greater number of total days, and a greater average length of 
stay. However, none of these differences were statistically significant.   
 
Quality of Life 
The summary scale of the QLQ C30 showed that intervention patients had 
significantly better overall QOL than those in the control condition. This difference 
appears to be a result of the significant differences in nausea and vomiting, appetite 
loss, physical and cognitive functioning (Table 3).   
 
<Table 3 about here> 
 
DISCUSSION 
The EAT intervention demonstrated superior nutritional status scores compared to 
controls as measured by the PG-SGA at the critical time point at the end of RT. 
Following RT, the nutritional status of all patients improved, suggesting that patients 
resumed their usual eating and drinking as RT side effects subsided. These findings 
indicate that a behavioural intervention conducted during RT reduces eating 
difficulties, and supports the nutritional guidelines15 that long-term nutritional 
intervention is not necessary for most patients. 
 
Averaged across all time periods, intervention patients were more likely to be 
categorised as well nourished (SGA category A), lost a lower percentage of their body 
weight and were less likely to lose >10% of their baseline weight. These results all 
indicate that the EAT intervention was an effective method of improving or 
maintaining nutritional status in HNC patients receiving RT. 
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Intervention patients had significantly fewer RT interruptions. These secondary 
findings are important because they are a possible mechanism explaining the 
association between malnutrition and reduced survival found in previous studies.  
 
In addition to reducing nutritional decline and improving nutrition related 
outcomes, the EAT intervention, which included training the dietitians in a simple 
depression screen and referral where indicated, showed a reduction in depression 
scores on the PHQ-9. Without adding any new services or time to the dietetic 
consult, the timely referral to whatever service was available locally resulted in 
significantly reduced depressive symptoms in HNC patients undergoing RT. This 
reinforces the current recommendations that dietitians should be screening for 
depression15.  
 
A potential criticism of the study is that despite being significant, the difference in 
PG-SGA score was small (β =-1.53). Because there are no published minimum 
important differences for the PG-SGA, alternative assessments of the meaningfulness 
of the effect are necessary. Some context of the size of the difference can be gained by 
comparing the intervention parameter estimate to that of other variables in the 
linear mixed model. The improvement on PG-SGA score for EAT was seven times 
greater than that of the most common dietetic intervention of feeding tube insertion 
(β =-.21 SE±.64). In fact, the intervention effect on PG-SGA was only smaller than 
the non-modifiable factors of hospital and cancer type. The clinical significance of 
EAT is further supported by the difference in PG-SGA scores being associated with 
improvements in other clinically meaningful outcomes such as the dieticians’ 
Subjective Global Assessment of nutritional status, and overall quality of life scores 
using the EORTC QLQ-C30. 
 
A second limitation of the study was the potential for assessor bias. Although they 
were not part of the intervention, it was not possible to guarantee that the outcome 
assessors in the hospitals were unaware of the treatment period. Nevertheless the 
overall intervention effect remains even when the subjective physical exam  
component of the PG-SGA was removed from the analysis. 
 
Strengths of the study are the very high ecological validity, being provided by 
practising clinicians in working Australian radiation oncology units. The ongoing 
cost of the intervention was very low, not requiring any additional physical or 
personnel resources and being integrated into existing dietetic sessions.  
 
Further research is underway in long-term follow up of mortality, intervention 
acceptability, cost effectiveness and examination of the efficacy of the different 
intervention elements.  
 
This trial is the first of its kind internationally to demonstrate significant and 
clinically meaningful benefits of psychological strategies, delivered by dietitians, to 
improve malnutrition in HNC patients. Intervention participants exhibited better 
nutrition, less weight loss, lower depression scores, fewer RT interruptions and 
better QOL scores. The EAT intervention is an effective and achievable intervention 
that has shown improvement in a multi-centre trial around Australia. It should be 
considered for use in all RT departments in which malnutrition in HNC patients is a 
problem.  
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Figure 1. Principles of EAT & EAT to LIVE 
 
Figure 2. Consort diagram 
 
Figure 3. PG-SGA Parts A, B, C & D across all time points, overlayed with 95% CI of 
the baseline-adjusted model margins comparing intervention and controls 
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Table 1. Baseline Participant Characteristics  
Variable Control n(%) Intervention n(%) 
   
Male 126 (83) 118 (76) 
   
Aboriginal or Torres Strait Islander 3 (2) 3 (2) 
   
Non-English speaker at home 11 (7) 11 (7) 
   
Marital Status    
Married/Defacto 102 (68) 91 (59) 
 Separated/Divorced/Widowed 32(21) 37 24) 
 Single never married 17 (11) 23 (15) 
   
Highest level of education   
 Primary School 2 (1) 2 (1) 
 High School 72 (47) 83 (53) 
 University/Vocational College 76 (51) 70 (45) 
 Other 1 (1) 0 (0) 
   
Depression (PHQ-9)   
Minimal 98 (67) 98 (64) 
Mild to Moderate 39 (27) 51 (34) 
Moderately Severe to Severe 9 (6) 3 (2) 
   
Tumour site   
 Nasopharynx 12 (8) 11 (7) 
 Oropharynx 83 (55) 88 (56) 
 Oral Cavity 30 (20) 36 (23) 
 Larynx 14 (9) 15 (10) 
 Hypopharynx 9 (6) 2 (1) 
 Unknown Primary 3 (2) 4 (3) 
   
Tumour stage   
 I 6 (4) 6 (4) 
 II 22 (15) 17 (11) 
 III 25 (17) 32 (20) 
 IV 98 (65) 101 (65) 
   
Dysphagia rating (CTCAE)   
Absent 98(66) 108(69) 
Symptomatic, able to eat 27(18) 20(13) 
Symptomatic, altered eating 16(11) 20(13) 
Severely altered eating 8(5) 8(5) 
Life threatening 0(0) 0(0) 
   
Concurrent Chemotherapy 121 (80) 126 (82) 
Platinum-based  101 (67) 104 (67) 
Cetuximab 19 (13) 21 (21) 
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Post-Operative Radiotherapy 44 (29) 53 (34) 
   
Prophylactic PEG 33 (22) 38 (25) 
Prophylactic NGT 3 (2) 4 (3) 
   
Continuous Variables Mean(SD) Mean(SD) 
Age 58 (10) 58 (11) 
   
Prescribed Radiation (Gy) 68 (4) 68 (3) 
Fraction number 34 (2) 34 (2) 
   
Nutritional Status (PG-SGA) 5 (5) 5 (5) 
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Table 2. Comparisons of Primary and Secondary Outcomes 
Outcome  Means, % or Counts Statistic (95% CI) p 
  Control Intervention    
Primary Outcome 
PG-SGA + Last wk 16.24 14.71 β=-1.53 (-2.93 -.13) .03 
        
Secondary Outcomes 
        
SGA category A* 1st wk 87% 84% OR=2.88 (1.38 5.99) <.01 
 Last wk 21% 34%     
 1 mth 43% 49%     
 3 mth 69% 71%     
        
>10% weight loss Last wk 37% 24% OR=.23 (.06 .86) .03 
 1 mth 55% 39%     
 3 mth 63% 49%     
        
Percentage Weight loss 9.88 8.64 β=-1.24 (-2.35 -.13) .03 
        
PHQ-9 depression score 6.68 5.79 β=-.88 (-1.74 -.02) .04 
        
RT interruptions  14% 8% OR=.23 (.06 .92) .04 
        
Unplanned admissions  130 100 IRR=.73 (.52 1.03) .07 
        
Mean length of stay  6.1 4.1 β=-1.80 (-4.09 .50) .13 
        
Total days   922 653     
+Higher score indicates worse nutritional status/risk   
*SGA A = well nourished B= moderately malnourished C= severely malnourished 
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Table 3. Intervention vs Control in LMM of mean Health Related Quality of Life 
(QLQ C30) across End of Treatment, 1 Month Post RT & 3 Months Post RT 
Category Scale β (95% CI) p 
Total HRQOL score  .45 (.35 .54) <.01 
      
Global Health  
(higher is better) 
 
Global Health Status .97 (-2.53 4.48) .57 
Functioning Scales Role functioning 3.76 (-1.54 9.06) .16 
(higher is better) Physical Functioning 4.60 (1.07 8.13) .01 
 Emotional 
Functioning 
3.31 (-.06 6.68) .05 
 Cognitive 
Functioning 
5.34 (1.47 9.12) <.01 
 Social Functioning 2.93 (-1.87 7.35) .23 
      
Symptom Scales Fatigue -3.30 (-7.60 1.01) .13 
(lower is better) Nausea & Vomiting -7.12 (-10.85 -3.37) <.01 
 Pain .83 (-3.85 5.51) .73 
 Dyspnoea  -3.43 (-7.14 .28) .07 
 Insomnia .27 (-4.96 5.49) .91 
 Appetite Loss -7.18 (-13.35 1.01) .02 
 Constipation -2.01 (-6.21 2.18) .35 
 Diarrhoea -1.03 (-4.08 2.03) .51 
 Financial Difficulties -2.03 (-7.32 3.26) .45 
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Summary 
Malnutrition during head and neck cancer is associated with poorer morbidity and 
mortality outcomes. This trial assessed the effectiveness of a psychological 
intervention delivered by dietitians to prevent malnutrition in head and neck cancer 
patients while having radiotherapy. Those patients that received the intervention had 
significantly better nutritional scores; lost less weight; had fewer radiotherapy 
interruptions; had lower depression scores; and reported a higher quality of life.  
 
